REFERENCES
- Fallon H J, Woods JW: Response of hyperlipoproteinemia to cholestyramine resin. JAMA 204: 1161, 1968
- Levy RI, Fredrickson DS, Kwiterovich PO, et al: The shift of familial hypercholesterolemia from a frustrating to an eminently treatable problem. Clin Res 17: 474, 1969
- Parkinson TM, Gundersen K, Nelson NA: Effects of colestipol (U-26,597A), a new bile acid sequestrane on serum lipids in experimental animals and man. Atherosclerosis 11: 531, 1970
- Farquhar JW, Smith RE, Dempsey ME: Effect of beta sitosterol on serum lipids in young men with arteriosclerotic heart disease. Circulation 14: 77, 1956
- Strisower EH, Adamson G, Strisower B: Treatment of hyperlipidemias. Am J Med 45: 488, 1968
- Eder H: Drugs used in the prevention and treatment of atherosclerosis. In Goodman LS, Gilman A (Editors): The Pharmacological Basis of Therapeutics. Ed 3. New York, The Macmillan Company, 1965, p 754
- Lees RS, Wilson DE: The treatment of hyperlipidemia. N Engl J Med 284: 186, 1971
- Levy RI, Quarfordt SH, Brown WV, et al: The efficacy of Clofibrate (CPIB) in familial hyperlipoproteinemias. Adv Exp Med Biol 4: 377, 1968
- Langer T, Levy RI: Acute muscular syndrome associated with administration of Clofibrate. N Engl J Med 279: 856, 1968
- LaRosa JC, Brown WV, Frommer PL, et al: Clo-fibrate-induced ventricular arrhythmia. Am J Cardiol 23: 266, 1969
- Berge KG, Achor RW, Christensen NA, et al: Hypercholesterolemia and nicotinic acid. A long-term study. Am J Med 31: 24, 1961
- Khachadurian AK: Cholestyramine therapy in patients homozygous for familial hypercholesterolemia (familial hypercholesterolemic xanthomatosis). Atherosclerosis 8: 177, 1968
- Zelis R, Mason DT, Braunwald E, et al: Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. J Clin Invest 49: 1007, 1970
- Lees RS, Wilson DE: Reciprocity of plasma low and very low density lipoproteins in pypemia. J Clin Invest 49: 56a, 1970
- Glueck CJ, Levy RI, Fredrickson DS: Norethindrone acetate, postheparin lipolytic activity and plasma triglycerides in familial types I, III, IV and V hyperlipoproteinemia. Ann Intern Med 75: 345, 1971
- Dayton S, Pearce ML: Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. Am J Med 46: 751, 1969
- Kannel WB, Castelli WP, Gordon T, et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74: 1, 1971